148 / 172
148
first-line therapy for early-onset rheumatoid arthritis. Arthritis
Rheum 2009;60:2272-83.
45. Emery P, Breedveld F, van der Heijde D, Ferraccioli G,
Dougados M, Robertson D, et al. Two-year clinical and
radiographic
results
with
combination
etanercept-
methotrexate therapy versus monotherapy in early
rheumatoid arthritis: a two-year, double-blind, randomized
study. Arthritis Rheum 2010;62:674-82.
46. Lineker SC, Bell MJ, Badley EM. Evaluation of an inter-
professional educational intervention to improve the use of
arthritis best practices in primary care. J Rheumatol
2011;38:931-7.
47. Katchamart W, Johnson S, Lin HJ, Phumethum V, Salliot C,
Bombardier C. . Predictors for remission in rheumatoid
arthritis patients: a systematic review. Arthritis Care Res
2010;62:1128-43.
48. Ferraz-Amaro I, Machín S, Carmona L, González-Alvaro I,
Díaz-González F; EMECAR study group. Pattern of use and
safety of non-steroidal anti-inflammatory drugs in rheumatoid
arthritis patients. A prospective analysis from clinical practice.
Reumatol Clin 2009;5:252-8.
49. Solomon DH, Rassen JA, Glynn RJ, Lee J, Levin R,
Schneeweiss S. The comparative safety of analgesics in older
adults with arthritis. Arch Intern Med 2010 13;170:1968-76.
50. Hoes JN, Jacobs JW, Verstappen SM, Bijlsma JW, Van der
Heijden GJ. Adverse events of low- to medium-dose oral
glucocorticoids in inflammatory diseases: a meta-analysis. Ann
Rheum Dis 2009;68:1833-8.
51. Furst DE, Pangan AL, Harrold LR, Chang H, Reed G,
Kremer JM, et al. Greater likelihood of remission in
rheumatoid arthritis patients treated earlier in the disease
course: results from the Consortium of Rheumatology
Researchers of North America registry. Arthritis Care Res
(Hoboken) 2011;63:856-64.